| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 150.238 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 150.238 | 80 |
| GSM780709 | Untreated after 4 days (C3_1) | 151.876 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 140.825 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 155.058 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 161.628 | 81 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 129.501 | 79 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 125.804 | 78 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 113.792 | 77 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 111.695 | 77 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 128.787 | 79 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 105.246 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 173.928 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 142.506 | 80 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 146.576 | 80 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 163.642 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 124.735 | 78 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 149.048 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 81.5113 | 72 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 76.0087 | 71 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 101.508 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 68.6066 | 69 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 90.8329 | 74 |